Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 192,039	$ 220,882
Restricted cash	394	394
Accounts receivable, net of allowances of $893 and $1,265	77,355	109,104
Inventories	56,739	47,551
Prepaid expenses and other current assets	17,359	31,517
Total current assets	343,886	409,448
Property, plant and equipment, net	179,282	459,276
Operating lease right-of-use assets	19,103	20,854
Finance lease right-of-use assets	5,934
Other long-term assets	6,771	5,566
Total assets	554,976	895,144
Current liabilities:
Accounts payable	39,931	44,361
Accrued expenses	16,681	36,495
Deferred revenue	2,645	2,199
Finance obligation for sale and leaseback transactions	3,929	4,028
Operating lease liabilities	3,339	3,279
Finance lease liabilities	1,408
Long term debt - current portion	13,500	19,750
Total current liabilities	81,433	110,112
Revolving line of credit	28,956	42,131
Long term debt	95,416	94,961
Finance obligation for sale and leaseback transactions long-term	8,353	10,087
Operating lease liabilities long-term	22,305	23,148
Finance lease liabilities long-term	3,679
Total liabilities	240,142	280,439
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, $0.00001 par value per share; 5,000,000 shares authorized, no shares issued and outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.00001 par value per share; 250,000,000 shares authorized, 82,174,358 and 82,040,468 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	0	0
Additional paid-in capital	1,276,310	1,274,932
Accumulated deficit	(961,476)	(660,227)
Total stockholders’ equity	314,834	614,705
Total liabilities and stockholders’ equity	$ 554,976	$ 895,144